8 Pediatric Neuro-Oncology Mark T. Jennings Introduction The predominant neoplastic diseases of the central nervous system (CNS) that arise during childhood are categorized as “low-grade” astrocytomas (AST), malignant gliomas (MG),…
14 Spinal Metastases Tali Siegal and Tzony Siegal Introduction Spinal metastases may affect different components of the spine, and the approach to treatment depends on correct localization of the affected…
17 Neurological Complications of Radiation Therapy Damien Ricard, Carole Soussain, Anthony Béhin and Daysi Chi Introduction Radiation therapy (RT) plays a key role in neuro-oncology but is associated with significant,…
1 Pathology and Molecular Genetics of Common Brain Tumors V. Peter Collins Introduction This chapter aims to provide an outline of the surgical pathology and the recognized genetic and molecular…
15 Neoplastic Meningitis Marc C. Chamberlain Introduction Neoplastic meningitis (NM) is the result of seeding of the leptomeninges by malignant cells. NM is not infrequent, and is becoming more common…
7 Oligodendrogliomas Jeremy H. Rees Introduction Oligodendrogliomas (OD) and oligoastrocytomas (OA), otherwise known as mixed gliomas, and their anaplastic variants are less common than astrocytomas (discussed in the previous chapter)…
4 Advanced Imaging of Adult Brain Tumors with MRI and PET Geoffrey S. Young, Jan Stauss and Srinivasan Mukundan Abstract We briefly review the major advanced MRI techniques used in…
10 Management of Intramedullary Spinal Cord Tumors Nicholas H. Post and Paul R. Cooper Intramedullary spinal cord tumors (IMSCTs) are rare, a fact that is reflected by the paucity of…
18 Paraneoplastic Disorders Myrna R. Rosenfeld and Josep Dalmau Introduction Paraneoplastic neurological disorders (PND) are a heterogeneous group of disorders that can affect any part of the neuraxis, including the…
16 Neurotoxicity of Chemotherapy Kate Scatchard and Siow Ming Lee Introduction Neurological side effects are a common complication following chemotherapy, and can adversely affect clinical management of the cancer patient….
